 Parallel analysis to assess identify potential candidate surrogate biomarkers of disulfiram efficacy, as well as identification using proteomic, biochemical and molecular genetic studies of potential predictive biomarkers of disulfiram sensitivity or resistance will be performed. Surrogate biomarker analysis will focus on in vivo ubiquitin-proteosomal system inhibition, cell cycle and DNA damage. 